Telegram
График акции Aura Biosciences, Inc.
О компании
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011, a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications, including choroidal metastases and is in Phase 2 dose-escalation trial. Подробнее
| EBITDA | -0.0236 |
|---|---|
| Число акций ао | 0.03962 млрд |
| P/BV | 3.26 |
| EV/EBITDA | 1.3711 |
| Цена ао | 7.63 |
| ISIN | US05153U1079 |
| Сайт | https://www.aurabiosciences.com |
| Изменение цены за день: | 0% (8.99) |
|---|---|
| Изменение цены за неделю: | +19.87% (7.5) |
| Изменение цены за месяц: | +22.65% (7.33) |
| Изменение цены за 3 месяца: | +23.83% (7.26) |
| Изменение цены за полгода: | +14.52% (7.85) |
| Изменение цены за год: | -26.01% (12.15) |
| Изменение цены с начала года: | 0% (8.99) |
Все параметры ⇨
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Matrix Capital Management | 6922870 | 13.98 |
| Eventide Asset Management LLC | 5802682 | 11.72 |
| Adage Capital Partners GP L.L.C. | 4225000 | 8.53 |
| Citadel Advisors Llc | 3631294 | 7.34 |
| Medicxi Ventures Management (Jersey) Ltd | 3039892 | 6.14 |
| Nantahala Capital Management, LLC | 2643720 | 5.34 |
| Blackrock Inc. | 2098745 | 4.24 |
| Vanguard Group Inc | 1730431 | 3.5 |
| Decheng Capital Management III (Cayman), LLC | 1163123 | 2.35 |
| Goldman Sachs Group Inc | 1037299 | 2.1 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Dr. Elisabet de los Pinos Ph.D. | Founder, CEO, President & Director | 895.16k | 1974 (50 лет) |
| Ms. Julie B. Feder | Chief Financial Officer | 604.2k | 1971 (53 года) |
| Dr. Mark Plavsic D.V.M., Ph.D. | Chief Technology Officer | N/A | 1961 (63 года) |
| Mr. Patrick Nealon | Senior Vice President of Clinical Development Operations | N/A | |
| Dr. Bruce Brown M.D. | Senior VP & Therapeutic Area Head of Urologic Oncology | N/A | |
| Dr. Anthony Daniels M.D. | Therapeutic Area Head of Ocular Oncology | N/A | |
| Dr. Richard Mountfield Ph.D. | Senior Vice President of Regulatory Affairs & Quality | N/A | |
| Mr. Conor Kilroy | General Counsel & Secretary | N/A | 1982 (42 года) |
| Dr. Jill J. Hopkins M.D. | Chief Medical Officer & President of Research and Development | N/A | 1965 (59 лет) |
Адрес: United States, Boston. MA, 80 Guest Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.aurabiosciences.com
Сайт: https://www.aurabiosciences.com
